Research Alliance Corp. I
Status: Closed Deal
U=S
| IPO Proceeds, $M | $135.70M |
|---|---|
| IPO Date | Jul 8, 2020 |
| CEO | Peter Kolchinsky, Ph.D. |
| Left Lead | Jefferies |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24 months |
| IPO Sector | Healthcare ▶ |
| IPO Geography | Global |
| Target Company | POINT Biopharma |
| Deal Announced | Mar 15, 2021 |
| Deal Size, $M | $639.20M |
| Deal Sector | Healthcare |
| Deal Geography | Global |
| SEC Filings |
www.sec.gov 
|
| Approval Vote | Jun 29, 2021 |
| Amendment Vote | TBD |
| Closing Date | Jun 30, 2021 |
Formerly RACA
PNT
| Price | 12.5 |
|---|---|
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in to view structure, cap table, and calendar of events.